A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands
- PMID: 8164519
- DOI: 10.1016/0169-328x(94)90374-3
A comparative autoradiographic study of 5-HT1D binding sites in human and guinea-pig brain using different radioligands
Abstract
Quantitative receptor autoradiography was used to examine the 5-hydroxytryptamine (5-HT, serotonin) binding sites labelled with serotonin-5-O-carboxymethyl-glycyl-[125I]tyrosinamide ([125I]GTI) in human and guinea-pig brain. Competition experiments using 5-carboxamidotryptamine (5-CT), 3-(1,2,5,6-tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one (CP 93129) and sumatriptan revealed monophasic displacement curves in various brain regions, suggesting that a homogeneous population of 5-HT1D binding sites was labelled. Displacement of [3H]5-HT (in the presence of 100 nM 8-hydroxy-2(N-dipropylamino)tetralin (8-OH-DPAT) and 100 nM mesulergine) with unlabelled GTI resulted in monophasic competition curves in substantia nigra, globus pallidus and central gray. In contrast, biphasic displacement was observed in hippocampus, nucleus accumbens, claustrum, caudate-putamen and frontal cortex. The distribution of [125I]GTI sites was compared to that of [3H]5-HT binding sites (under so-called '5-HT1D conditions', i.e. in the presence of 100 nM 8-OH-DPAT and 100 nM mesulergine, in order to block 5-HT1A and 5-HT1C sites, respectively) in human and guinea-pig brain. Qualitative analysis revealed differences in the distributions of [125I]GTI and [3H]5-HT binding sites. Regions such as CA3 and CA4 of the hippocampus, claustrum and putamen showed [3H]5-HT binding (under '5-HT1D conditions') but no [125I]GTI binding sites, indicating that [3H]5-HT labels besides a GTI sensitive (5-HT1D) receptor population, a non-5-HT1A/1B/1C/1D [3H]5-HT binding site in human and guinea-pig brain. The distribution of these non-5-HT1A/1B/1C/1D [3H]5-HT binding sites was studied with [3H]5-HT under conditions where 5-HT1A, 5-HT1C and 5-HT1D [3H]5-HT binding sites were saturated by the presence of 100 nM 8-OH-DPAT, 100 nM mesulergine and 1 microM GTI. Significant densities of these non-5-HT1A/1B/1C/1D sites were observed in cortical areas, hippocampal structures, nucleus accumbens, amygdala, caudate-putamen and claustrum. It is concluded that [125I]GTI does not label the 5-HT1E binding site, since all competition curves obtained with this radioligand were monophasic. By contrast, [3H]5-HT labels non-5-HT1A/1B/1C/1D [3H]5-HT binding sites, but it remains to be established whether these sites represent a single receptor population.
Similar articles
-
[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.Naunyn Schmiedebergs Arch Pharmacol. 1995 Sep;352(3):263-75. doi: 10.1007/BF00168556. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8584041
-
Autoradiographic characterisation and localisation of 5-HT1D compared to 5-HT1B binding sites in rat brain.Naunyn Schmiedebergs Arch Pharmacol. 1993 Jun;347(6):569-82. doi: 10.1007/BF00166939. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 8361548
-
Quantitative autoradiography of 5-HT1D and 5-HT1E binding sites labelled by [3H]5-HT, in frontal cortex and the hippocampal region of the human brain.Brain Res. 1994 Feb 28;638(1-2):85-94. doi: 10.1016/0006-8993(94)90636-x. Brain Res. 1994. PMID: 8199879
-
Serotonin receptors in brain revisited.Brain Res. 2016 Aug 15;1645:46-9. doi: 10.1016/j.brainres.2015.12.042. Epub 2015 Dec 29. Brain Res. 2016. PMID: 26740406 Review.
-
Serotonin 5-HT1D receptors.Ann N Y Acad Sci. 1990;600:168-81; discussion 181-2. doi: 10.1111/j.1749-6632.1990.tb16880.x. Ann N Y Acad Sci. 1990. PMID: 2252308 Review.
Cited by
-
Serotonin and psilocybin activate 5-HT1B receptors to suppress cortical signaling through the claustrum.Nat Commun. 2025 Aug 19;16(1):7733. doi: 10.1038/s41467-025-62980-8. Nat Commun. 2025. PMID: 40830107 Free PMC article.
-
Chick Hippocampal Formation Displays Subdivision- and Layer-Selective Expression Patterns of Serotonin Receptor Subfamily Genes.Front Physiol. 2022 Apr 8;13:882633. doi: 10.3389/fphys.2022.882633. eCollection 2022. Front Physiol. 2022. PMID: 35464081 Free PMC article.
-
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function.Pharmacol Rev. 2021 Jan;73(1):310-520. doi: 10.1124/pr.118.015552. Pharmacol Rev. 2021. PMID: 33370241 Free PMC article. Review.
-
[3H]sumatriptan labels both 5-HT1D and 5-HT1F receptor binding sites in the guinea pig brain: an autoradiographic study.Naunyn Schmiedebergs Arch Pharmacol. 1995 Sep;352(3):263-75. doi: 10.1007/BF00168556. Naunyn Schmiedebergs Arch Pharmacol. 1995. PMID: 8584041
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous